Introduction
Randomized
controlled trial therapeutic medicine selected is the Moxibustion drug applied
for relieving pain in patients with primary dysmenorrhea. The paper provides a
critical appraisal of Moxibustion on its main causes of use in managing and
controlling menstrual pain (Mingxiao et. al., 2017). The study research
evaluates effectiveness in the treatment as well as economic issues associated
with the drugs. The scope of the study is restricted to evaluating the
effectiveness of the drug. The study does not cover the efficiency of drug
especially in encountering pain that occurs as a result of menstrual pain. The
research study also analyzes the effects of drug especially on psychological
effects during and after the treatment process. The main purpose of selecting
the Moxibustion drug is to understand how menstruating woman can manage the
effects excessive breeding as well release of endometrial prostaglandin. The
purpose of the paper is to reduce the repeated monthly period complications
that come as a result of uterine hypercontractility (Mingxiao et. al., 2017).
The intended purpose is reducing uterine blood flow as well as managing and
controlling an effect that triggers hypersensitive pain fibers. I have selected this topic on Moxibustion
since the complications during a menstrual period are more common in women and
young girls during their puberty period. The effects of menstruation during
puberty and later in the adulthood cause greater issues on human health.
Considering the repetitive nature of women menstrual conditions and considering
the quality of good life among women, women who encounter menstrual
complications usually suffer from severe physiological and psychological
symptoms thus influencing their quality of life and daily routines. Among young
girls, several issues arise such as absenteeism from school classes (Mingxiao
et. al., 2017). Such issues are some of the social and personal distress among
women that have triggered to this study research.
Evaluation of Introduction Section
Aims
- The
aim of study research is providing detailed supportive clinical evidence
that Moxibustion is effective and efficient in the treatment of
prostaglandin and induction of quick recovery from menstrual pain.
- The
study research majors at guaranteeing good and standing evidence through
sampling individuals to prove the drug.
- The
study research focuses on using random participants as well as
conventional drug control mechanism as well as a critical trial to verify
and validate the effectiveness of Moxibustion.
Literature Review
Pharmacological
and non-pharmacological drugs are one of the essential drugs for treating
dysmenorrhea and relieving menstrual pain. Other optional drugs such as
non-steroidal anti-inflammatory drugs (NSAID) and oral contraceptives are
optional drugs that can be used in alleviating symptoms of prostaglandin. NSAID
can be used in the treatment of prostaglandin and menstrual pains. However, the
NSAID drugs are associated with strange adverse effects that encourage
gastrointestinal disorders, nephrotoxic effects as well as hepatotoxic
disorders (Mingxiao et. al., 2017). Another disadvantage of using NSAID drugs
is the fact that they don’t prevent progressive effects of disease progression.
Use of oral contraceptives continuously has shown a reduction in recurrence
conditions such as dysmenorrhea, reduction in nonspecific pelvic pains, delayed
presentation of dysmenorrhea as well as reducing effects of recurrent rate of
endometrioma. However, women who discontinue taking the drugs experience
radical recurrence revealing that protective nature of NSAID vanishes
immediately after discontinuation (Mingxiao et. al., 2017). Moreover, NSAID
drugs do not guarantee total relieving of menstrual pains for all women.
An
alternative solution involves the implementation of traditional medications as
well as other medicines to certainly guarantee total treatment of prostaglandin
and menstrual pains. Alternative measures that guarantee treatment of menstrual
problems include the use of acupuncture, Tuina or massage, moxibustion among
other treatment procedures. Treatment using moxibustion include a combination
of both pharmacological and no pharmacological materials. The treatment process
involves physical touch. The effectiveness of the therapy is caused by chemical
stimulation and burning of Moxa. Heat stimulation from moxibustion is
associated with activating inflammatory responses that lead to induction of vascular
changes. According to systematic reviews, it is clear that moxibustion is
effective in the treatment of dysmenorrhea and relieving menstrual pain.
Evaluation of Methods
Subjects
The
sampling method applied involved random selection of participants where two
different types of treatments were considered. The treatment strategies
administered included moxibustion and conventional drug. Participants agreed to
informed consent and all voluntarily availed themselves for the testing
procedures. The population involved in sampling process from various
universities. Ethical approvals were received from relevant authorities. The
population involved included 2134 eligible participants were randomly selected
and divided into control group, and group tested using moxibustion (Mingxiao
et. al., 2017). The study was determined to analyze all sampled individuals,
however, only 30 individuals whose blood was obtained to carry out the study.
As a result of financial and economic challenges, the blood samples for all participants
could not be obtained. The groups were selected by being given moxibustion and
control drug at random. The treatment took place for exactly three months and
then observations were made.
Apparatus / Instrumentation
The
observations were later made through measuring menstrual pain intensity using
Visual Analogue Scale (VAS). The comparisons on the pain intensity between
moxibustion and pain killers were evaluated to come up with differences. Other
conditions tested included defining me the intensity of pain in the serum
compounds. The follow up of various testing were conducted for three
months. The major apparatus involved in
the study process included apparatus and instrumentations such as Visual
Analogue Scale to determining the levels of pain.
Control groups
Participants
were allocated different groups at random through using a specific group ratio
of 1: 1. Treatment strategies were organized such that various groups received
different treatments. For example, a particular group was required to take
ibuprofen. The group required taking moxibustion; they took two different TCM
patterns such as diagnostic pattern 1 and diagnostic pattern 2 (Mingxiao et.
al., 2017). The participants received
moxibustion drugs once per day for a session of seven days. The medication was
taken for three sessions over a period of three menstrual cycles.
Subject Assignment
The
individuals in various groups were characterized by individuals with histories
of the regular menstrual cycle. The individuals required included people with a
history of having three normal menstrual cycles. There were individuals who had
experienced the pain of menstrual cycle from moderate to severe condition.
However, patients with some conditions and criteria were excluded. Patients having irregular menstrual cycles
were excluded from the sample. Other excluded cases involved women in
lactation, pregnant condition, or women planning to become pregnant within a
year (Mingxiao et. al., 2017). Women who had taken NSAID or who had been
treated with Moxibustion were eliminated from the study. All ethical issues
such as informed consent and reasons why participants could not take part in
the study were explained.
Treatment parameters
Individual
participants in the control group were required to take fend for relieving pain
as well as 0.3 grams of capsules after
an hour for two days over a period of three menstrual cycles (Mingxiao et. al.,
2017). Every session was initialized after a day of the menstrual cycle for
three days. The time and quantity amount of pain killers were recorded as well.
Rosenthal & Hawthorn Effects
The
study research was mainly based on the pragmatic trials. The analysis
restrictions were based on the effectiveness of Moxibustion in treating
menstrual pain. The study research did not analyze effects of the drug on
psychological factors. The study failed to analyze the effects because there
were no blind procedures or sham control.
Evaluation of the Results
After
the treatment follows up, the results obtained after patients were involved in
the 1st month and 2nd month revealed that the intensity of menstrual pain
measured using VAS reduced in the control group that used pain killers and
NSAID drugs. However, in the group that used moxibustion, there was no
significant reduction of pain noted. The differences from statistical analysis
revealed (P<0.001). At the beginning of the 3rd month the both groups
indicated corresponding changes in the reduction of menstrual pain. There were
no significant differences in changes in pain experiences. Resulting
statistical analysis revealed (0.07, 95%CI -0.38 to 0.52, P = 0.76) (Mingxiao
et. al., 2017). At the end of 3rd-month
pain intensity measured from the participants taking moxibustion was significantly
lower compared to that of the control group. The pain had reduced by far. The
statistical analysis was as revealed p (-0.87, 95%CI -1.32 to -0.42,
P<0.001). After the six months, the menstrual pain had completely stopped in
the group treated using moxibustion. The results are as shown below.
Selection
Statistics
The time and efficiency of the moxibustion can lead to making
inferences that reveal that moxibustion drug is more superior effective and
efficient compared to other pain killers and NSAID drugs. Individuals can be
recommended to use moxibustion instead of pain killers or NSAID drugs.
Moxibustion is, therefore, the best drug that should be recommended for
patients suffering from dysmenorrhea and relieving menstrual pain. The
generalization made by the author is significant and statistically supported
using statistical analysis.
Interpretation of
Findings
In the first two months the impact of drugs on the pain had
no much difference from each other. However the pain substantially decreased
with increase with, treatment days. Three months after treatment with
moxibustion, the group using the drug encountered reduction of menstrual pain
between 1.29 to 1.06 days (Mingxiao et. al., 2017). The improvement experienced by the population that
was used as control test experienced pain improvement almost immediately after
taking the drugs. However, at the
end of three months pain persisted and
remained constant. The reduction of menstrual pains in the group taking
moxibustion took a little longer to experience any changes in reduction of
pain. However with time the effects of
pain reduced significantly and ceased to exist. The menstrual pains were no
longer experienced among the group that took moxibustion. The observations
shows that the pain killers and NSAID drugs reduces pains almost immediately
but temporarily. On the other hand moxibustion takes a longer period before
reduction of pain. However, after the reduction the pain is never experienced
in progressing menstrual cycles.
Conclusion
The research study inferences and observations are valid many
studies provide adequate support that shows that dysmenorrhea and relieving
menstrual pain generally known as PD is not just a disease that concerns of
uterus it can also cause other complications in the brain. The use of
Moxibustion has been confirmed both by biological medical scientists as well as
by scientists who deal with psychiatrist operations. Proved mechanisms where
Moxibustion can be applied for treatment of menstrual pains since it regulates
hypercontractivity of uterus during menstrual cycle. The study research has
found out that Moxibustion drug can be used to solve a complication that occurs
as a result of pain associated with abdominal complications during menstral
cycle. Its influence is more significant after three months of treatment.
Moxibustion is the best therapeutic drug that can be used especially for long
term management of diseases and complications that occur as a result of
endometrial prostaglandin. The analysis has shown positive attributes and
altitudes that can promote the drug especially for complete acquisition of
controlling and managing menstrual pain. The drug therefore guarantees economic
support, for young ladies as well as beneficial in solving menstrual problems
that can repeat over a series of period.
References
Mingxiao
Y., Xiangzhu C., Linna B., Lixing L.,
Jiao C. , Siyi Y., Zheng Y.,, Hongzhi
T., Ling Y., Xi W., Jie Y., Fanrong L., (2017).Moxibustion for pain relief in
patients with primary dysmenorrhea: A randomized controlled trial
Sherry Roberts is the author of this paper. A senior editor at MeldaResearch.Com in affordable custom research papers. If you need a similar paper you can place your order from legitimate essay writing service services.
Comments
Post a Comment